Cleveland Jewish News: William Schiemann, associate professor of general medical sciences, led a team of researchers who found a link between a micro ribonucleic acid molecule and late-stage breast cancer. “Our micro RNA inactivates [a protein called] Bim, and we think this leads to chemo resistance to these metastatic cancers,” Schiemann said. Lower Bim levels, coupled with higher miR-181a levels, allow the spread of cancer.
Medicine’s William Schiemann and researchers target molecule’s role in late-stage breast cancer
- Mandel School’s Rob Fischer discusses study into how a house is linked to a child’s academic performance
- Florence Harkness Memorial Chapel featured for its architecture, history
- Sociology’s Áine Ní Léime was cited for researcher on women and Social Security
- CWRU, Cleveland Clinic cited for their role in Cleveland’s growth in biomedical innovation, development
- Vice President Joe Biden talks about importance of work being done at Case Comprehensive Cancer Center